Logo image of ENGS

ENERGYS GROUP LTD (ENGS) Stock Fundamental Analysis

NASDAQ:ENGS - KYG3040B1041 - Common Stock

4.58 USD
+0.17 (+3.85%)
Last: 9/2/2025, 8:00:01 PM
Fundamental Rating

1

ENGS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 53 industry peers in the Construction & Engineering industry. ENGS may be in some trouble as it scores bad on both profitability and health. ENGS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ENGS had negative earnings in the past year.
In the past year ENGS has reported a negative cash flow from operations.
ENGS Yearly Net Income VS EBIT VS OCF VS FCFENGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -500K -1M -1.5M -2M

1.2 Ratios

ENGS has a Return On Assets of -12.77%. This is amonst the worse of the industry: ENGS underperforms 81.13% of its industry peers.
Industry RankSector Rank
ROA -12.77%
ROE N/A
ROIC N/A
ROA(3y)-19.74%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENGS Yearly ROA, ROE, ROICENGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 40

1.3 Margins

ENGS has a Gross Margin of 22.31%. This is in the better half of the industry: ENGS outperforms 69.81% of its industry peers.
The Profit Margin and Operating Margin are not available for ENGS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ENGS Yearly Profit, Operating, Gross MarginsENGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

ENGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ENGS has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ENGS has been reduced compared to a year ago.
ENGS Yearly Shares OutstandingENGS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M
ENGS Yearly Total Debt VS Total AssetsENGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

ENGS has an Altman-Z score of 1.88. This is not the best score and indicates that ENGS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ENGS (1.88) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.88
ROIC/WACCN/A
WACC8.71%
ENGS Yearly LT Debt VS Equity VS FCFENGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -2M -4M

2.3 Liquidity

A Current Ratio of 0.51 indicates that ENGS may have some problems paying its short term obligations.
ENGS has a Current ratio of 0.51. This is amonst the worse of the industry: ENGS underperforms 84.91% of its industry peers.
ENGS has a Quick Ratio of 0.51. This is a bad value and indicates that ENGS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.41, ENGS is doing worse than 86.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.41
ENGS Yearly Current Assets VS Current LiabilitesENGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.47% over the past year.
The Revenue has grown by 59.88% in the past year. This is a very strong growth!
EPS 1Y (TTM)51.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.47%
Revenue 1Y (TTM)59.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%59.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ENGS Yearly Revenue VS EstimatesENGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ENGS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ENGS Price Earnings VS Forward Price EarningsENGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ENGS Per share dataENGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ENGS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENERGYS GROUP LTD

NASDAQ:ENGS (9/2/2025, 8:00:01 PM)

4.58

+0.17 (+3.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.14%
Ins Owner ChangeN/A
Market Cap65.27M
AnalystsN/A
Price TargetN/A
Short Float %21.62%
Short Ratio0.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.9
BVpS-0.19
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.31%
FCFM N/A
ROA(3y)-19.74%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 23.46%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.41
Altman-Z 1.88
F-Score5
WACC8.71%
ROIC/WACCN/A
Cap/Depr(3y)173.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.47%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)59.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%59.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-127.65%
OCF growth 3YN/A
OCF growth 5YN/A